Adrenal Steroid Synthesis Inhibitors [MoA] - N0000175921
Pharmacologic Class Information
| Pharmacologic Code | N0000175921 |
| Pharmacologic Name | Adrenal Steroid Synthesis Inhibitors |
| Pharmacologic Uses |
|
| Pharmacologic Concept | Mechanisms of Action - [MoA] |
| Pharmacologic Concept Description | This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept. |
NDC Products with Adrenal Steroid Synthesis Inhibitors
The table contains 2 products whose active ingredient are classified under the same pharmacologic class Adrenal Steroid Synthesis Inhibitors [MoA].
| NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Status | |
|---|---|---|---|---|---|---|---|
| 68118-455 | Metopirone | Non-Proprietary Name: Metyrapone | Capsule, Gelatin Coated | Oral | Esteve Pharmaceuticals, S.a. | ACTIVE | |
| 76336-455 | Metopirone | Non-Proprietary Name: | Laboratoire Hra Pharma | ||||
| 76336-455 | Metopirone | Non-Proprietary Name: Metyrapone | Capsule, Gelatin Coated | Oral | Hra Pharma Rare Diseases | ACTIVE |